(IN BRIEF) Symrise has made a strategic equity investment in U.S.-based biotech firm Cellibre to drive innovation in sustainable biomanufacturing. The collaboration will accelerate the commercialization of natural flavor ingredients and cosmetic bioactives produced through precision fermentation. By combining Symrise’s … Read the full press release
